Eloxx Pharmaceuticals, Inc.NASDAQ: ELOX

ELOX: Sixth Amendment adds bridge and Tranche 2 loans, PIK interest, and new agent SD MF 4 LLC

· Issued by Eloxx Pharmaceuticals, Inc.

The Sixth Amendment to the Loan and Security Agreement, effective July 10, 2024, introduces a bridge loan, a new Tranche 2 Advance, and allows for payment-in-kind interest and optional or mandatory debt-to-equity conversion in a qualified financing. SD MF 4 LLC replaces Hercules as agent, and the amendment includes a broad release of claims and updated collateral arrangements.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Eloxx Pharmaceuticals

All Eloxx Pharmaceuticals news releases